David Young - Aug 16, 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
President & CEO, Director, 10%+ Owner
Signature
/s/ David Young by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Aug 16, 2022
Transactions value $
$0
Form type
4
Date filed
8/23/2022, 04:30 PM
Previous filing
Aug 9, 2022
Next filing
Oct 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Gift $0 -9.25K -2.39% $0.00 378K Aug 16, 2022 Direct
holding PCSA Common Stock 574K Aug 16, 2022 By Young-Plaisance Revocable Trust
holding PCSA Common Stock 695K Aug 16, 2022 By Family Entities
holding PCSA Common Stock 37.5K Aug 16, 2022 By CorLyst, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.